4th Quarter - Report

W STRATEGIES, LLC for ABBOTT LABORATORIES

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013. Education with respect to implementation issues in the Medicare Competitive Bidding program, specifically as it relates to access to brand name diabetes test strips.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2085 (113th)

Taxation/Internal Revenue Code TAX

Monitored legislative efforts to reform the corporate tax system.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Education on the importance of proper infant nutrition, including the role of infant formula in the WIC program. Monitored legislative initiatives to encourage labeling of genetically modified foods. Educated staff about FDA regulation and certain medical foods.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Agriculture AGR

H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 with respect to Goodlatte-Scott amendment to reform the dairy program.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1947 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.